A phase I study of dovitinib in combination with capecitabine and oxaliplatin in upfront treatment of advanced colorectal and gastric cancer with a dose expansion cohort in advanced gastric cancer.
W. M. D. Tai
No relevant relationships to disclose
W. S. Ooi
No relevant relationships to disclose
J. Y. Ngeow
No relevant relationships to disclose
N. Deng
No relevant relationships to disclose
H. Wang
No relevant relationships to disclose
C. K. Tham
No relevant relationships to disclose
H. Y. Lim
No relevant relationships to disclose
S. P. Choo
No relevant relationships to disclose
P. Tan
Research Funding - Novartis
H. C. Toh
Research Funding - Novartis
I. B. Tan
Research Funding - Novartis